Lavipharm S.A. (ATH:LAVI)

Greece · Delayed Price · Currency is EUR

1.200

-0.020 (-1.64%)

At close: Mar 20, 2026

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Medicines	52.76M	47.44M	34.18M	34.28M	31.74M
Medicines Growth	11.22%	38.78%	-0.28%	8.01%	10.97%
Services	187.00K	400.00K	1.45M	1.43M	1.48M
Services Growth	-53.25%	-72.32%	1.12%	-3.38%	-1.14%
Parapharmaceuticals	-	-	3.43M	4.02M	4.42M
Parapharmaceuticals Growth	-	-	-14.59%	-9.18%	26.59%
Total	52.95M	47.84M	39.06M	39.72M	37.64M
Total Growth	10.68%	22.48%	-1.68%	5.54%	12.06%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Greece	28.44M	21.55M	31.18M	27.58M	25.85M
Greece Growth	32.02%	-30.91%	13.07%	6.69%	23.25%
European Union	18.83M	22.75M	12.20M	10.41M	11.37M
European Union Growth	-17.22%	86.44%	17.16%	-8.39%	3.56%
Other countries	5.68M	3.55M	2.62M	1.73M	422.00K
Other countries Growth	59.99%	35.18%	51.41%	310.66%	-74.27%
Total	52.95M	47.84M	46.01M	39.72M	37.64M
Total Growth	10.68%	3.98%	15.82%	5.54%	12.06%

Source: S&P Global Market Intelligence.